Clinical Trials Arena on MSN3d
MSD’s subcutaneous Keytruda non-inferior to IV version of blockbuster drugCompared to the IV infusion of the blockbuster cancer drug Keytruda, subcutaneous Keytruda was able to reduce the time patients spent in the chemotherapy chair.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback